European pharmaceutical industry response to COVID-19
25.02.20
As the impact of COVID-19 continues to be felt across the world, the biopharmaceutical industry in Europe remains committed to global efforts to care for those affected, contain the outbreak and develop resources to tackle future outbreaks.
For more information, please click here to view our dedicated section.